← Back to headlines
AbbVie and Genmab Secure EU Label Expansion for Cancer Drug Tepkinly
AbbVie and Genmab have received approval for an EU label expansion for their drug Tepkinly, specifically for the treatment of follicular lymphoma.
7 Jul, 16:38 — 7 Jul, 16:38
Sources
Showing 1 of 1 sources
Related Stories
BOJ to debate rate rise, inflation much closer to 2% target: governor
12m ago
Markets React to Middle East Tensions as Oil Prices Surge and Gold Falls
32m ago
Apple Announces Executive Compensation Packages for Ternus and Cook
45m ago
Bessent Urges BOJ Chief to Take Decisive Action to Stabilize Yen
57m ago